# Observational Lupus Nephritis studies recruiting: 30 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 30 trials that are observational for Lupus Nephritis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Lupus Nephritis studies: 30 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/lupus-nephritis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 30
- Recruiting or not yet: 30
- Read on: November 19, 2026

## Trials

The 25 newest of 30, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07931170 | Pediatric Longitudinal Glomerular Disease: a PNRC Multi-Institutional Cohort Study | Pediatric Nephrology Research Consortium | Observational | Recruiting | IgA Nephropathy (IgAN), IgA Vasculitis, Idiopathic Immune Complex Glomerulonephritis, C3 Glomerulopathy, Membranous... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931170) |
| November 10, 2026 | NCT07930091 | Molecular Biomarkers for Discriminating Lupus Nephritis in SLE | Egyptian Chinese University | Observational | Not yet recruiting | Systemic Lupus Erythematosus Nephritis, Systemic Lupus Erthematosus (SLE) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930091) |
| October 29, 2026 | NCT07902622 | Pakistan Arthritis and Connective Tissue Disease Network - Systemic Lupus Erythematosus | Foundation University Islamabad | Observational | Recruiting | SLE - Systemic Lupus Erythematosus | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902622) |
| September 23, 2026 | NCT07837544 | Diastolic Dysfunction and Inflammatory Biomarkers in Lupus Nephritis | Assiut University | Observational | Not yet recruiting | Lupus Nephritis, Diastolic Dysfunction, Systemic Lupus Erythematosus, Heart Failure, Diastolic | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07837544) |
| September 8, 2026 | NCT07805863 | Serum MPO-DNA Complexes as a Biomarker of Disease Activity in Systemic Lupus Erythematosus | Assiut University | Observational | Not yet recruiting | Systemic Lupus Erythematosus, Lupus Nephritis | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805863) |
| August 25, 2026 | NCT07783711 | Predictors of ICU Admission and In-Hospital Mortality in Hospitalized Patients With Lupus Nephritis: The Prognostic Value of... | Sponsor not shown (see the record) | Observational | Not yet recruiting | Lupus Nephritis (LN) | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783711) |
| August 21, 2026 | NCT07780045 | SII and SIRI as Prognostic Biomarkers in Lupus Nephritis | Assiut University | Observational | Not yet recruiting | Lupus Nephritis, Systemic Lupus Erythematosus, Kidney Diseases | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780045) |
| August 13, 2026 | NCT07763821 | Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis. | Assiut University | Observational | Not yet recruiting | System Lupus Erythematosus(SLE) | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763821) |
| July 23, 2026 | NCT07721857 | Neutrophil Extracellular Traps and Lupus Nephritis | Assiut University | Observational | Not yet recruiting | Lupus Nephritis (LN) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07721857) |
| July 22, 2026 | NCT07719322 | Non Invasive Assessment of Subclinical Atherosclerosis and Cardiovascular Risk Using TYG Index in Lupus Nephritis | Assiut University | Observational | Not yet recruiting | Systemic Lupus Erthematosus (SLE), Lupus Nephritis (LN) | 156 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07719322) |
| June 24, 2026 | NCT07666711 | Biomarker Development for Autoimmune Disorders Involving the Kidneys | Oslo University Hospital | Observational | Recruiting | Lupus Nephritis, Systemic Lupus Erythematosus | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07666711) |
| April 1, 2026 | NCT07505576 | Anti-alpha-actinin Antibodies and Lupus Nephritis Activity | Assiut University | Observational | Not yet recruiting | Lupus Nephritis | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07505576) |
| February 11, 2026 | NCT07403188 | A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 | Kyverna Therapeutics | Observational | Recruiting | Refractory Lupus Nephritis, Myasthaenia Gravis, Stiff Person Syndrome, Rheumatoid Arthritis (RA), Multiple Sclerosis... | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07403188) |
| August 19, 2025 | NCT07130448 | The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis | Assiut University | Observational | Not yet recruiting | Lupus Nephritis (LN), SLE - Systemic Lupus Erythematosus, Biomarkers | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07130448) |
| July 8, 2025 | NCT07053891 | LUPKYNIS Drug-use Results Survey | Otsuka Pharmaceutical Co., Ltd. | Observational | Recruiting | Lupus Nephritis | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07053891) |
| April 15, 2025 | NCT06927219 | Research Accelerated by You Lupus Registry | Lupus Foundation of America | Observational | Recruiting | Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Cutaneous Lupus Erythematosus (CLE) | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06927219) |
| November 12, 2024 | NCT06682507 | High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort) | First Affiliated Hospital, Sun Yat-Sen University | Observational | Recruiting | Lupus Nephritis (LN) | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06682507) |
| October 23, 2024 | NCT06654024 | Urinary Congophilia as an Indicator of Activity of Lupus Nephritis | Assiut University | Observational | Not yet recruiting | Lupus Nephritis (LN) | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06654024) |
| October 15, 2024 | NCT06642402 | Monitoring Lupus Nephritis Through Urinary Extracellular Vesicles | Sponsor not shown (see the record) | Observational | Recruiting | Systemic Lupus Erythematosus Nephritis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06642402) |
| September 24, 2024 | NCT06610422 | Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients | Assiut University | Observational | Not yet recruiting | Lupus Nephritis | 159 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06610422) |
| September 19, 2024 | NCT06588192 | Renal Survival in Patients with Lupus Nephritis | Assiut University | Observational | Not yet recruiting | Lupus Nephritis (LN) | 97 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06588192) |
| August 21, 2024 | NCT06564181 | The Relation Between Serum Zinc and Lupus Nephritis | Assiut University | Observational | Not yet recruiting | Lupus Nephritis | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06564181) |
| July 30, 2024 | NCT06527872 | Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN | GlaxoSmithKline | Observational | Recruiting | Lupus Nephritis | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06527872) |
| December 12, 2023 | NCT06167174 | Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis | Chinese SLE Treatment And Research Group | Observational | Recruiting | Lupus Nephritis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06167174) |
| July 6, 2023 | NCT05934149 | Lupus Landmark Study: A Prospective Registry and Biorepository | Lupus Research Alliance | Observational | Recruiting | Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Neuropsychiatric Systemic Lupus Erythematosus | 3,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05934149) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Assiut University | 12 |
| Seoul National University Hospital | 1 |
| [Otsuka Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/otsuka-pharmaceutical-co-ltd) | 1 |
| Lupus Foundation of America | 1 |
| Sun Yat-sen University | 1 |
| Kyverna Therapeutics | 1 |
| Foundation University Islamabad | 1 |
| First Affiliated Hospital, Sun Yat-Sen University | 1 |
| Chinese SLE Treatment And Research Group | 1 |
| Egyptian Chinese University | 1 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 1 |
| Pediatric Nephrology Research Consortium | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
| Oslo University Hospital | 1 |
| The Rogosin Institute | 1 |
| Lupus Research Alliance | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 7 |
| China | 3 |
| Japan | 2 |
| Egypt | 2 |
| South Korea | 1 |
| Pakistan | 1 |
| France | 1 |
| Italy | 1 |
| Belgium | 1 |
| Norway | 1 |
| Denmark | 1 |
| Canada | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Locksmiths in the United States](https://specstream.ai/data/businesses/locksmiths/united-states)
- [Mental health clinics in the United States](https://specstream.ai/data/businesses/mental-health-clinics/united-states)
- [Occupational medicine clinics in the United States](https://specstream.ai/data/businesses/occupational-medicine-clinics/united-states)
- [Payroll companies in the United States](https://specstream.ai/data/businesses/payroll-companies/united-states)
- [Podiatrists in the United States](https://specstream.ai/data/businesses/podiatrists/united-states)
- [Public health clinics in the United States](https://specstream.ai/data/businesses/public-health-clinics/united-states)
